Myostatin as a therapeutic target in Amyotrophic Lateral Sclerosis

Neurochemistry International

Volumn 61, Issue 6, 2012, Pages 931-935

  Walsh, Frank S ^a   Rutkowski, Julia Lynn ^a  

^a Ossianix Inc   (United States)

Author keywords

Amyotrophic Lateral Sclerosis; Antibody therapeutics; Myostatin; Shark VNAR; Single domain antibody

Indexed keywords

ANTIBODY; MOLECULAR SCAFFOLD; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RK35; MYO 29; MYOSTATIN; RAMATERCEPT; RK 35; TIRASEMTIV; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BECKER MUSCULAR DYSTROPHY; BINDING AFFINITY; CONFERENCE PAPER; DISEASE COURSE; DRUG BINDING SITE; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TARGETING; DRUG WITHDRAWAL; DUCHENNE MUSCULAR DYSTROPHY; EPISTAXIS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GINGIVA BLEEDING; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE INNERVATION; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; QUALITY OF LIFE; SKELETAL MUSCLE; SKIN BLOOD VESSEL DISORDER;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; HUMANS; MYOSTATIN;

CHONDRICHTHYES;

EID: 84868201804     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.07.016     Document Type: Conference Paper

References (34)

1. L. Bradley, P.J. Yaworsky, and F.S. Walsh Myostatin as a therapeutic target for musculoskeletal disease Cell Mol. Life Sci. 65 2008 2119 2124
2. Z. Cao, Y. Gao, K. Deng, G. Williams, P. Doherty, and F.S. Walsh Receptors for myelin inhibitors: structures and therapeutic opportunities Mol. Cell Neurosci. 43 2010 1 14
3. C.N. Christian, P.G. Nelson, J. Peacock, and M. Nirenberg Synapse formation between two clonal cell lines Science 196 1977 995 998
4. B.J. Fennell, A. Darmanin-Sheehan, S.E. Hufton, V. Calabro, L. Wu, M.R. Müller, W. Cao, D. Gill, O. Cunningham, and W.J. Finlay Dissection of the IgNAR V domain: molecular scanning and orthologue database mining define novel IgNAR hallmarks and affinity maturation mechanisms J. Mol. Biol. 400 2010 155 170
5. G.S. Eisenbarth, F.S. Walsh, and M. Nirenberg Monoclonal antibody to a plasma membrane antigen of neurons Proc. Natl. Acad. Sci. USA 76 1979 4913 4917
6. B.W. Festoff Amyotrophic Lateral Sclerosis: current and future therapeutic strategies Drugs 51 1996 28 44
7. D.S. Gill Protein pharmaceuticals: discovery and preclinical development Adv. Exp. Med. Biol. 655 2009 28 36
8. J.D. Glass New drugs for ALS: how do we get there? Exp. Neurol. 233 2012 112 117
9. A.S. Greenberg, D. Avila, M. Hughes, A. Hughes, E.C. McKinney, and M.F. Flajnik A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks Nature 374 1995 168 173
10. E.L. Holzbaur, D.S. Howland, N. Weber, K. Wallace, Y. She, S. Kwak, L.A. Tchistiakova, E. Murphy, J. Hinson, R. Karim, X.Y. Tan, P. Kelley, K.C. McGill, G. Williams, C. Hobbs, P. Doherty, M.M. Zaleska, M.N. Pangalos, and F.S. Walsh Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis Neurobiol. Dis. 23 2006 697 707
11. M. Katsuno, H. Adachi, H. Banno, K. Suzuki, F. Tanaka, and G. Sobue Transforming growth factor-β signaling in motor neuron diseases Curr. Mol. Med. 11 2011 48 56
12. L.S. Krivickas, R. Walsh, and A.A. Amato Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029 Muscle Nerve 39 2009 3 9
13. P.N. Leigh, and L.C. Wijesekera Motor neuron disease: focusing the mind on ALS: updated practice parameters Nat. Rev. Neurol. 6 2010 191 192
14. S. McCroskery, M. Thomas, L. Platt, A. Hennebry, T. Nishimura, L. McLeay, M. Sharma, and R. Kambadur Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice J. Cell Sci. 118 2005 3531 3541
15. A.C. McPherron, A.M. Lawler, and S.J. Lee Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member Nature 387 1997 83 90
16. T.M. Miller, S.H. Kim, K. Yamanaka, M. Hester, P. Umapathi, H. Arnson, L. Rizo, J.R. Mendell, F.H. Gage, D.W. Cleveland, and B.K. Kaspar Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. USA 103 2006 19546 19551
17. J.A. Morren, and N. Galves-Jiminez Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis Expert Opin. Investig. Drugs 21 2012 297 320
18. B.M. Morrison, J.L. Lachey, L.C. Warsing, B.L. Ting, A.E. Pullen, K.W. Underwood, R. Kumar, D. Sako, A. Grinberg, V. Wong, E. Colantuoni, J.S. Seehra, and K.R. Wagner A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis Exp. Neurol. 217 2009 258 268
19. J.R. Moskal, D. Trisler, M.D. Schneider, and M. Nirenberg Purification of a membrane protein distributed in a topographic gradient in chicken retina Proc. Natl. Acad. Sci. USA 83 1986 4730 4733
20. S.B. Nuttall, and R.B. Walsh Display scaffolds: protein engineering for novel therapeutics Curr. Opin. Pharmacol. 8 2008 609 615
21. S.P. Oh, and E. Li The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse Genes Dev. 14 1997 1812 1826
22. R. Prinjha, S.E. Moore, M. Vinson, S. Blake, R. Morrow, G. Christie, D. Michalovich, D.L. Simmons, and F.S. Walsh Inhibitor of neurite outgrowth in humans Nature 403 2000 383 384
23. A.J. Russell, J.J. Hartman, A.C. Hinken, A.R. Muci, R. Kawas, L. Driscoll, G. Godinez, K.H. Lee, D. Marquez, W.F. Browne, M.M. Chen, D. Clarke, S.E. Collibee, M. Garard, R. Hansen, Z. Jia, P. Lu, H. Rodriguez, K.G. Saikali, J. Schaletzky, V. Vijayakumar, D.L. Albertus, D.R. Claflin, D.J. Morgans, B.P. Morgan, and F. Malik Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases Nature Med. 378 2011 667 675
24. J.M. Savitt, D. Trisler, and D.C. Hilt Molecular cloning of TOPAP: a topographically graded protein in the developing chick visual system Neuron 14 1995 253 261
25. O. Schulte-Herbrüggen, A. Braun, S. Rochlitzer, M.C. Jockers-Scherübl, and R. Hellweg Neurotrophic factors: a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases? Curr. Med. Chem. 14 2007 2318 2329
26. R.W. Sperry Chemoaffinity in the orderly growth of nerve fibre patterns and connections Proc. Natl. Acad. Sci. USA 50 1963 703 710
27. V.A. Streltsov, J.A. Carmichael, and S.D. Nuttall Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype Protein Sci. 14 2005 2901 2909
28. D. Trisler, and F. Collins Corresponding spatial gradients of TOP molecules in the developing retina and optic tectum Science 237 1987 1208 1209
29. K.R. Wagner, J.L. Fleckenstein, A.A. Amato, R.J. Barohn, K. Bushby, D.M. Escolar, K.M. Flanigan, A. Pestronk, R. Tawil, G.I. Wolfe, M. Eagle, J.M. Florence, W.M. King, S. Pandya, V. Straub, P. Juneau, K. Meyers, C. Csimma, T. Araujo, R. Allen, S.A. Parsons, J.M. Wozney, E.R. Lavallie, and J.R. Mendell A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy Ann. Neurol. 63 2008 5615 5671
30. F.S. Walsh, and P. Doherty Neural cell adhesion molecules of the immunoglobulin superfamily: role in axon growth and guidance Annu. Rev. Cell Dev. Biol. 13 1997 425 456
31. L.A. Whittemore, K. Song, X. Li, J. Aghajanian, M. Davies, S. Girgenrath, J.J. Hill, M. Jalenak, P. Kelley, A. Knight, R. Maylor, D. O'Hara, A. Pearson, A. Quazi, S. Ryerson, X.Y. Tan, K.N. Tomkinson, G.M. Veldman, A. Widom, J.F. Wright, S. Wudyka, L. Zhao, and N.M. Wolfman Inhibition of myostatin in adult mice increases skeletal muscle mass and strength Biochem. Biophys. Res. Commun. 300 2003 965 971
32. L.C. Wijesekera, and P.N. Leigh Amyotrophic lateral sclerosis Orphanet J. Rare Dis. 4 2009 3
33. A.F. Williams, G. Galfrè, and C. Milstein Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes Cell 12 1977 63 73
34. L. Zinman, and M. Culdowicz Emerging targets and treatments in amyotrophic lateral sclerosis Lancet Neurol. 10 2011 481 490.